These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29675927)

  • 1. Tributyltin reduces the levels of serum adiponectin and activity of AKT and induces metabolic syndrome in male mice.
    Yan H; Guo H; Cheng D; Kou R; Zhang C; Si J
    Environ Toxicol; 2018 Jul; 33(7):752-758. PubMed ID: 29675927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tributyltin chloride leads to adiposity and impairs metabolic functions in the rat liver and pancreas.
    Bertuloso BD; Podratz PL; Merlo E; de Araújo JF; Lima LC; de Miguel EC; de Souza LN; Gava AL; de Oliveira M; Miranda-Alves L; Carneiro MT; Nogueira CR; Graceli JB
    Toxicol Lett; 2015 May; 235(1):45-59. PubMed ID: 25819109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tributyltin impacts in metabolic syndrome development through disruption of angiotensin II receptor signaling pathways in white adipose tissue from adult female rats.
    Ceotto Freitas-Lima L; Merlo E; Campos Zicker M; Navia-Pelaez JM; de Oliveira M; Dos Santos Aggum Capettini L; Nogueira CR; Versiani Matos Ferreira A; Sousa Santos SH; Bernardes Graceli J
    Toxicol Lett; 2018 Dec; 299():21-31. PubMed ID: 30172001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tributyltin in male mice disrupts glucose homeostasis as well as recovery after exposure: mechanism analysis.
    Li B; Guo J; Xi Z; Xu J; Zuo Z; Wang C
    Arch Toxicol; 2017 Oct; 91(10):3261-3269. PubMed ID: 28397090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental obesogen tributyltin chloride leads to abnormal hypothalamic-pituitary-gonadal axis function by disruption in kisspeptin/leptin signaling in female rats.
    Sena GC; Freitas-Lima LC; Merlo E; Podratz PL; de Araújo JF; Brandão PA; Carneiro MT; Zicker MC; Ferreira AV; Takiya CM; de Lemos Barbosa CM; Morales MM; Santos-Silva AP; Miranda-Alves L; Silva IV; Graceli JB
    Toxicol Appl Pharmacol; 2017 Mar; 319():22-38. PubMed ID: 28161095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tributyltin causes obesity and hepatic steatosis in male mice.
    Zuo Z; Chen S; Wu T; Zhang J; Su Y; Chen Y; Wang C
    Environ Toxicol; 2011 Feb; 26(1):79-85. PubMed ID: 19760618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels.
    Liu J; Dong H; Zhang Y; Cao M; Song L; Pan Q; Bulmer A; Adams DB; Dong X; Wang H
    Sci Rep; 2015 May; 5():9886. PubMed ID: 26017184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tributyltin differentially promotes development of a phenotypically distinct adipocyte.
    Regnier SM; El-Hashani E; Kamau W; Zhang X; Massad NL; Sargis RM
    Obesity (Silver Spring); 2015 Sep; 23(9):1864-71. PubMed ID: 26243053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice.
    Chamorro-García R; Sahu M; Abbey RJ; Laude J; Pham N; Blumberg B
    Environ Health Perspect; 2013 Mar; 121(3):359-66. PubMed ID: 23322813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
    Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
    Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
    Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tributyltin triggers lipogenesis in macrophages via modifying PPARγ pathway.
    Jie J; Ling L; Yi Y; Tao L; Liao X; Gao P; Xu Q; Zhang W; Chen Y; Zhang J; Weng D
    Environ Pollut; 2021 Feb; 271():116331. PubMed ID: 33383419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
    Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
    Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome alterations induced by tributyltin exposure are associated with increased body weight, impaired glucose and insulin homeostasis and endocrine disruption in mice.
    Zhan J; Ma X; Liu D; Liang Y; Li P; Cui J; Zhou Z; Wang P
    Environ Pollut; 2020 Nov; 266(Pt 3):115276. PubMed ID: 32835916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
    Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
    J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tributyltin exposure induces gut microbiome dysbiosis with increased body weight gain and dyslipidemia in mice.
    Guo H; Yan H; Cheng D; Wei X; Kou R; Si J
    Environ Toxicol Pharmacol; 2018 Jun; 60():202-208. PubMed ID: 29738946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice.
    Premaratna SD; Manickam E; Begg DP; Rayment DJ; Hafandi A; Jois M; Cameron-Smith D; Weisinger RS
    Int J Obes (Lond); 2012 Feb; 36(2):233-43. PubMed ID: 21556046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance.
    Amin RH; Mathews ST; Camp HS; Ding L; Leff T
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E28-37. PubMed ID: 19843873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.